Also in regard to other gynecologic tumors, such as ovarian cancer, the role of SIRT1 expression is inconsistent: regarding the most common ovarian cancer types (serous, mucinous, endometrioid, clear-cell), an increased SIRT1 expression is significantly correlated to shorter survival rates (Mvunta et al. 2017). Here, SIRT1 is linked to ovarian carcinoma.